SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: 8-K
Document Type: EX-4.1
Date Filed: 2025-08-27
Accession Number: 0001213900-25-081175
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025081175/ea025480001ex4-1_synergy.htm

Chunk 0 of 8
Word Count: 1399
Character Count: 8381

Document Content:

Exhibit 4.1

THE REGISTERED HOLDER OF THIS SECURITY BY ITS
ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS SECURITY, OR ANY UNDERLYING SECURITIES, EXCEPT AS HEREIN PROVIDED,
AND THE HOLDER OF THIS SECURITY AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHOCATE THIS SECURITY , OR ANY OF THE UNDERLYING
SECURITIES, FOR A PERIOD OF ONE HUNDRED AND EIGHTY (180) DAYS FOLLOWING THE DATE OF THIS SECURITY.

COMMON STOCK PURCHASE WARRANT

For the Purchase of
Shares of Common Stock,

Par Value $0.00001 per Share,

Synergy CHC Corp.

Warrant Shares:

Initial Exercise Date: February 21, 2026

THIS CERTIFIES THAT, pursuant to that certain
Underwriting Agreement by and between Synergy CHC Corp., a Nevada corporation (the “Company”), and Bancroft Capital,
LLC dated August 25, 2025 (the “Underwriting Agreement”),
(“Holder”) and its assignees, as registered holders of this purchase warrant (this “Warrant”), is
entitled, at any time or from time to time from February 21, 2026 (the “Initial Exercise Date”), the date that
is one hundred and eighty (180) days after the date of the pricing of the Company’s common stock, $0.00001 par value per share (the
“Common Stock”), and at or before 5:00 p.m., Eastern time, on the applicable expiration date for each portion of this
Warrant, as follows: (i) twenty-five percent (25%) of the Warrant Shares (as defined below) shall expire on the date that is three (3)
years from the Effective Date, (ii) twenty-five percent (25%) of the Warrant Shares shall expire on the date that is four (4) years from
the Effective Date, and (iii) the remaining fifty percent (50%) of the Warrant Shares shall expire on the date that is five (5) years
from the Effective Date (each, a “Termination Date” with respect to the applicable portion of the Warrant), but not
thereafter, to subscribe for, purchase and receive, in whole or in part, up to
shares of Common Stock (subject to adjustment hereunder, the “Warrant Shares”). If the Termination Date is a day on
which banking institutions are authorized by law to close, then this Warrant may be exercised on the next succeeding day which is not
such a day in accordance with the terms herein. During the period ending on the Termination Date, the Company agrees not to take any action
that would terminate this Warrant. This Warrant is initially exercisable at $2.75 per share of Common Stock (110% of the price of the
Common Stock sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section
3 hereof, the rights granted by this Warrant, including the exercise price per share and the number of shares of Common Stock
to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the
initial exercise price as set forth above or the adjusted exercise price as a result of the events set forth in Section 3 below,
depending on the context.

Section 1. Definitions.

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

“Common Stock
Equivalents” means any securities of the Company that would entitle the holder thereof to acquire shares of Common Stock.

“Effective Date”
means the date of the closing of the Offering pursuant to the Underwriting Agreement.

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

“Securities Act”
means the Securities Act of 1933, as amended.

“Trading Day” means a day on
which the Trading Market is open for trading.

“Trading Market”
means any of the following markets or exchanges on which the shares of Common Stock are listed or quoted for trading on the date in question:
the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York Stock Exchange
(or any successors to any of the foregoing).

“Transfer
Agent” means the transfer agent and registrar in respect of the shares of Common Stock.

Capitalized terms used but
not otherwise defined herein shall have the meanings ascribed to such terms in the Underwriting Agreement.

Section 2. Exercise.

Exercise of the purchase rights represented by
this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination
Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered
Holder at the address of the Holder appearing on the books of the Company) of a duly executed copy of the Notice of Exercise Form annexed
hereto. Within two (2) Trading Days following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price
for the shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States bank,
unless the cashless exercise procedure specified in Section 2(b) below is specified in the applicable Notice of Exercise.
Notwithstanding anything herein to the contrary (although the Holder may surrender the Warrant to, and receive a replacement Warrant from,
the Company), the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all
of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant
to the Company for cancellation within two (2) Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial
exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the
effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant
Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such
purchases. The Company shall deliver any objection to any Notice of Exercise Form within one (1) Trading Day of delivery of such notice.
The Holder by acceptance of this Warrant or any transferee, acknowledges and agrees that, by reason of the provisions of this Section
2, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder
at any given time may be less than the amount stated on the face hereof.

(a) Exercise Price.
The initial exercise price per share of the Common Stock under this Warrant shall be equal to 110% of the initial public offering price,
subject to adjustment under Section 3 (the “Exercise Price”).

(b) Cashless Exercise.
If at any time after the six (6) month anniversary of the Initial Exercise Date, there is no effective Registration Statement covering
the resale of the Warrant Shares by the Holder (or the prospectus does not meet the requirements of Section 10 of the Securities Act),
then this Warrant may also be exercised at the Holder’s election, in whole or in part and in lieu of making the cash payment otherwise
contemplated to be made to the Company upon such exercise, at such time by means of a “cashless exercise” in which the Holder
shall be entitled to receive a number of Warrant Shares equal to the number obtained by dividing [(A - B) times (C)] by (A), where:

(A)	=	the greater of (i) the arithmetic average of the VWAPs for the five (5) consecutive Trading Days ending on the date immediately preceding the date on which the Holder elects to exercise this Warrant by means of a “cashless exercise,” as set forth in the applicable Notice of Exercise or (ii) the VWAP for the Trading Day immediately prior to the date on which the Holder makes such “cashless exercise” election;

(B)	=	the Exercise Price of this Warrant, as adjusted hereunder, at the time of such exercise; and

(C)	=	the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise;